|
Volumn 362, Issue 9389, 2003, Pages
|
COMET: a proposed mechanism of action to explain the results and concerns about dose.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBAZOLE DERIVATIVE;
CARVEDILOL;
DRUG DERIVATIVE;
METOPROLOL;
METOPROLOL SUCCINATE;
PROPANOLAMINE DERIVATIVE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONGESTIVE HEART FAILURE;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
HEART RATE;
HUMAN;
METHODOLOGY;
NOTE;
STANDARD;
TREATMENT OUTCOME;
ADRENERGIC ALPHA-ANTAGONISTS;
ADRENERGIC ANTAGONISTS;
ADRENERGIC BETA-ANTAGONISTS;
CARBAZOLES;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HEART FAILURE, CONGESTIVE;
HEART RATE;
HUMANS;
METOPROLOL;
PROPANOLAMINES;
RESEARCH DESIGN;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0642316363
PISSN: None
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/s0140-6736(03)14422-4 Document Type: Note |
Times cited : (30)
|
References (0)
|